KardiaAI vs VX1+
AI Verdict
Choose KardiaAI if…
Choose KardiaAI if you need an FDA-cleared AI software library for analyzing ambulatory ECG rhythms to detect conditions like AFib, bradycardia, and tachycardia. This tool is ideal for integrating into mobile health applications or remote patient monitoring platforms, providing medical-grade accuracy for ongoing heart rhythm data analysis outside of a clinical procedure.
View KardiaAI →Choose VX1+ if…
Choose VX1+ if you are an electrophysiologist requiring real-time AI-powered assistance during cardiac ablation procedures for atrial fibrillation and atrial tachycardia. This software is specifically designed to identify abnormal electrograms and integrate with existing EP recording and 3D mapping systems, providing critical insights during interventional procedures.
View VX1+ →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | KardiaAI | VX1+ |
|---|---|---|
| Pricing | Subscription-based for advanced features and services. | Unknown |
| Deployment | Mobile app, cloud-based. | Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
KardiaAIKardiaAI is deployed as an API library for mobile and web platforms, and its subscription model suggests a focus on broad accessibility for patients and general practitioners. While VX1+ has a 'simple user interface' for a specialized surgical setting, KardiaAI's design for integration into everyday devices and direct-to-consumer pricing implies a higher emphasis on general usability for a wider audience.
Clinical Value
VX1+Both tools are FDA-cleared and offer significant clinical value. KardiaAI provides diagnostic insights for monitoring and early detection of arrhythmias. However, VX1+ offers real-time, AI-driven guidance during complex cardiac ablation procedures, directly assisting electrophysiologists in treatment and potentially improving procedural efficacy and patient outcomes in an invasive setting.
Pricing & Value
KardiaAIKardiaAI offers transparent, subscription-based pricing with clear monthly and annual options, making its value proposition easily understandable and accessible for individual users or smaller practices. VX1+'s pricing is not publicly available, making it impossible to assess its value directly against a known cost.
Enterprise Readiness
KardiaAIKardiaAI explicitly states HIPAA compliance and BAA availability, along with its API-first deployment, indicating clear readiness for integration into diverse healthcare systems and partner applications. While VX1+ integrates with existing EP lab infrastructure and is FDA-cleared, the explicit statements regarding HIPAA compliance and BAA are not provided in its specifications, making KardiaAI's enterprise readiness more explicitly documented for broader integration.
Innovation
VX1+Both leverage AI in cardiology, but VX1+ demonstrates a higher degree of specialized innovation by applying AI in real-time during complex, invasive cardiac ablation procedures. Its ability to provide AI-driven insights and annotate 3D anatomical maps to guide electrophysiologists during surgery represents a more advanced and impactful application of AI in an interventional setting compared to KardiaAI's automated ECG interpretation for monitoring.
Support & Docs
KardiaAIAliveCor, the company behind KardiaAI, provides extensive and easily accessible public support resources, including FAQs, user manuals, and direct contact options. While Volta Medical (VX1+) likely offers institutional support, readily available public documentation and support channels are less apparent, making KardiaAI's support more transparent and accessible for its broader user base.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | KardiaAI | VX1+ |
|---|---|---|
| Product Name | KardiaAI | VX1+ |
| Company | AliveCor | Volta Medical |
| Primary Use Case | AI software library for analyzing ambulatory ECG rhythms, detecting various cardiac conditions like AFib, bradycardia, and tachycardia. | AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia. |
| Key Detections / Functionality | AI-powered ECG analysis library; Detection of atrial fibrillation, bradycardia, tachycardia, normal sinus rhythm, Sinus Rhythm with Premature Ventricular Contractions (PVCs), Sinus Rhythm with Wide QRS, Sinus Rhythm with Supraventricular Ectopy (SVE); ECG noise filtering and noisy ECG detection; API library for integration. | Real-time manual or automatic annotation of 3D anatomical and electrical maps; Identification of spatio-temporal dispersed electrograms (DEs) during AF and AT procedures; AI-driven insights to assist electrophysiologists; Compatibility with existing 510(k)-cleared catheters and specific data acquisition systems; Simple user interface with color coding; Booster mode for increased sensitivity; Provides cycle length estimation. |
| Specialties | Cardiology, Emergency Medicine, Internal Medicine | Cardiology |
Videos
Demos, reviews, and walkthroughs featuring KardiaAI and VX1+.
More Comparisons
More matchups featuring KardiaAI or VX1+
Backers
Who funded each tool's parent company.